[
1. Bradford PA: Extended-spectrum β-lactamases in the 21th century: Characterisation, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001, 14: 933-951.10.1128/CMR.14.4.933-951.20018900911585791
]Search in Google Scholar
[
2. Jacoby GA: AmpC β-lactamases. Clin Microbiol Rev 2009, 22 (1): 161-182.10.1128/CMR.00036-08262063719136439
]Search in Google Scholar
[
3. Philippon A, Arlet G, Jacoby GA: Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 2002, 46(1): 1-11.10.1128/AAC.46.1.1-11.200212699311751104
]Search in Google Scholar
[
4. Sadeeq R, Tariq A, Ijaz A, Nazir AK, Bo H, Jian G: The growing genetic and functional diversity of extended spectrum beta lactamases. Biomed Res Int 2018, March 26: 9519718.10.1155/2018/9519718589227029780833
]Search in Google Scholar
[
5. Perez-Perez FJ, Hanson ND: Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40: 2153-2162.10.1128/JCM.40.6.2153-2162.200213080412037080
]Search in Google Scholar
[
6. Poole K: Pseudomonas aeruginosa: Resistance to the max. Front Microbiol 2011 (April 5), 2: 65.10.3389/fmicb.2011.00065312897621747788
]Search in Google Scholar
[
7. Berrazeg M, Jeannot K, Ntsogo Enguéné VY, Broutin I, Loeffert S, Fournier D, Plésiat P: Mutations in β-lactamase AmpC increase resistance of Pseudomonas aeruginosa isolates to antipseudomonal cephalosporins. Antimicrob Agents Chemother 2015, 59: 6248-6255.10.1128/AAC.00825-15457605826248364
]Search in Google Scholar
[
8. Paterson DL: Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs). Clin Microbiol Infect 2000, 6: 460-463.10.1046/j.1469-0691.2000.00107.x11168179
]Search in Google Scholar
[
9. Ali T, ur Rahman S, Zhang L, Shahid M, Zhang S, Liu G, Gao J, Han B: ESBL-producing Escherichia coli from cows suffering mastitis in China contain clinical class 1 integrons with CTX-M linked to ISCR1. Front Microbiol 2016, 7: 1931.10.3389/fmicb.2016.01931512780827965653
]Search in Google Scholar
[
10. Saidani M, Messadi L, Soudani A, Daaloul-Jedidi M, Chatre P, Chehida FB, Mamlouk A, Mahjoub W, Madec J-Y, Haenni M: Epidemiology, antimicrobial resistance, and entended-spectrum β-lactamase-producing Enterobacterales in clinical bovine mastitis in Tunisa. Microb Drug Resist 2018, 24 (8): 1242-1248.10.1089/mdr.2018.004929757079
]Search in Google Scholar
[
11. Ghatak S, Singha A, Sen A, Guha C, Ahuja A, Bhattacharjee U, Das S, Pradhan NR, Puro K, Jana C, Dey TK, Prashantkumar KL, Das A, Shakuntala I, Biswas U, Jana PS: Detection of New Delhi Metallo-β-lactamase and extended-spectrum β-lactamase genes in Escherichia coli isolated from mastitic milk samples. Transbound Emerg Dis 2013, 60: 385-389.10.1111/tbed.1211923870003
]Search in Google Scholar
[
12. Timofte D, Maciuca IE, Evans NJ, Williams H, Wattret A, Fick JC, Willams NJ: Detection and molecular characterisation of Escherichia coli CTX-M-15 and Klebsiella pneumoniae SHV-12 β lactamases from bovine mastitis isolates in the United Kingdom. Antimicrob Agents Chemother 2014, 58 (2): 789-794.10.1128/AAC.00752-13391087324247146
]Search in Google Scholar
[
13. Eisenberger D, Carl A, Balsliemke J, Kampf P, Nickel S, Schulze G, Valenza G: Molecular characterisation of extended-spectrum β-lactamase-producing Escherichia coli isolates from milk samples of dairy cows with mastitis in Bavaria, Germany. Microb Drug Resist 2018, 24 (4): 505-510.10.1089/mdr.2017.018228953418
]Search in Google Scholar
[
14. Pehlivanoglu F, Turutoglu H, Ozturk D: CTX-M-15-type extended-spectrum β-lactamase-producing Escherichia coli as causative agent of bovine mastitis. Foodborne Pathog Dis 2016, 13 (9): 477-482.10.1089/fpd.2015.211427182838
]Search in Google Scholar
[
15. Locatelli C, Scaccabarozzi L, Pisoni G, Moroni P: CTX-M1 ESBL-producing Klebsiella pneumoniae subsp. pneumoniae isolated from cases of bovine mastitis. J Clin Microbiol 2010, 48: 3822-3823.10.1128/JCM.00941-10295311520720020
]Search in Google Scholar
[
16. Wagner S, Gally DL, Argyle SA: Multidrug-resistant Escherichia coli from canine urinary tract infections tend to have commensal phylotypes, lower prevalence of virulence determinants and ampC-replicons. Vet Microbiol 2014, 169 (3-4) :171-178.10.1016/j.vetmic.2014.01.003396958324485933
]Search in Google Scholar
[
17. Valat C, Drapeau A, Beurlet S, Bachy V, Boulouis H-J, Pin R, Cazeau G, Madec J-Y, Haenni M: Pathogenic Escherichia coli in dogs reveals the predominance of ST372 and the human-associated ST73 extra-intestinal lineages. Front in Microbiol 2020, 11: 580.10.3389/fmicb.2020.00580718635832373083
]Search in Google Scholar
[
18. Pehlivanoglu F, Sababoglu E, Ozturk D, Turutoglu H: Characterisation of extended-spectrum β-lactamase genes of Klebsiella pneumoniae isolated from urinary tract infection of a dog. In: Proceedings of the 12th National Congress of Veterinary Microbiology; Kapadokya, Nevşehir, Türkiye; 2016. Pp. 19-20.
]Search in Google Scholar
[
19. Huber H, Zweifel C, Wittenbrink WW, Stephan R: ESBL-producing uropathogenic Escherichia coli from dog and cats in Switzerland. Vet Microbiol 2013, 162 (2-4): 992-996.10.1016/j.vetmic.2012.10.02923177909
]Search in Google Scholar
[
20. Kuan NL, Chang CW, Lee CA, Yeh KS: Extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae isolates from the urine of dogs and cats suspected of urinary tract infection in a Veterinary teaching hospital. Taiwan Vet J 2016, 42 (3): 143-148.10.1142/S1682648515500274
]Search in Google Scholar
[
21. Marques C, Belas A, Franco A, Aboim C, Gama LT, Pomba C: Increase in antimicrobial resistance and emergence of major international high-risk clonal lineages in dogs and cats with urinary tract infection: 16 year retrospective study. J Antimicrob Chemother 2018, 73 (2): 377-384.10.1093/jac/dkx401589075329136156
]Search in Google Scholar
[
22. CLSI: Performans standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. 5th edition. CLSI document Vet01S. Wayne, PA: Clinical and Laboratory Standards Institute; 2020.
]Search in Google Scholar
[
23. Winn W, Allen S, Janda W, Koneman E, Procop G, Schreckenberger P, Woods G: Koneman’s Color Atlas and Textbook of Diagnostic Microbiology. 6th edition, Philadelphia, USA: Lippincott Williams and Wilkins; 2006.
]Search in Google Scholar
[
24. Weisburg WG, Barns SM, Pelletier DA, Lane DJ: 16S ribosoma DNA amplification for phylogenetic study. J Bacteriol 1991, 173 (2): 697-703.10.1128/jb.173.2.697-703.19912070611987160
]Search in Google Scholar
[
25. Laudy AE, Róg P, Smolińska-Król K, Ćmiel M, Słoczyńska A, Patzer J, Dzieerzanowska D, Wolinowska R, Starosciak B, Tyski S: Prevalence of ESBL-producing Pseudomonas aeruginosa isolates in Warsaw, Poland, detected by various phenotypic and genotypic methods. Plos One 2017, 12 (6): e0180121.10.1371/journal.pone.0180121548919228658322
]Search in Google Scholar
[
26. Weldhagen GF, Poirel L, Nordmann P: Ambler class A extended-spectrum β-lactamases in Pseudomonas aeruginosa: novel development and clinical impact. Antimicrob Agents Chemother 2003, 47 (8): 2385-2392.10.1128/AAC.47.8.2385-2392.200316605612878494
]Search in Google Scholar
[
27. Polsfuss S, Bloemberg GV, Giger J, Meyer V, Böttger EC, Hombach M: Practical approach for reliable detection of AmpC β-lactamase producing Enterobactericeae. J Clin Microbiol 2011, 49 (8): 2798-2803.10.1128/JCM.00404-11314773521632895
]Search in Google Scholar
[
28. CLSI: Performance standards for antimicrobial susceptibility testing, 30th edition. CLSI Supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2020.
]Search in Google Scholar
[
29. Coudron PE: Inhibitor based methods for detecti on of plasmid mediated AmpC β-lactamases in Klebsiella spp., Escherichia coli, and Proteus mira bilis J Clin Microbiol 2005, 43 (8): 4163-4167.10.1128/JCM.43.8.4163-4167.2005123391316081966
]Search in Google Scholar
[
30. Heffernan HM, Woodhouse RE, Pope CE, Blackmore TK: Prevalence and types of extended-spectrum β-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand. Int J Antimicrob Agents 2009, 34: 544-549.10.1016/j.ijantimicag.2009.07.01419748232
]Search in Google Scholar
[
31. Jeong SH, Bae IK, Kwon SB, Lee JH, Song JS, Jung HI, Sung KH, Jang SJ, Lee SH: Dissemination of transferable CTX-M-type extended-spectrum β-lactamase-producing E. coli in Korea. J Appl Microbiol 2005, 98: 921–927.10.1111/j.1365-2672.2004.02526.x15752339
]Search in Google Scholar
[
32. Pehlivanoglu F, Turutoglu H, Ozturk D, Yardimci H: Molecular characterisation of ESBL-producing Escherichia coli isolated from healthy cattle and sheep. Acta Vet- Beograd 2016, 66 (4): 520-533.10.1515/acve-2016-0045
]Search in Google Scholar
[
33. Rodrigues-Martines JM, Poirel L, Nordmann P: Extended-spectrum cephalosporinases in P. aeruginosa. Antimicrob Agents Chemother 2009; 53 (5): 1766-1771.10.1128/AAC.01410-08
]Search in Google Scholar
[
34. CLSI: Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. 4th edition. CLSI document VET01-A4 and VET01-S2, Wayne, PA: Clinical and Laboratory Standards Institute; 2013.
]Search in Google Scholar
[
35. WHO (World Health Organisation): Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. https://www.who.int/publications
]Search in Google Scholar
[
36. Tark D-S, Moon DC, Kang HY, Kim S-R, Nam H-M, Lee H-S, Jung S-C, Lim S-K: Antimicrobial susceptibility and characterization of extended-spectrum β-lactamases in Escherichia coli isolated from bovine mastitic milk in South Korea from 2012 to 2015. J Dairy Sci 2017, 100 (5): 3463-3469.10.3168/jds.2016-1227628318579
]Search in Google Scholar
[
37. Ali T, ur Rahman S, Zhang L, Shahid M, Han D, Gao J, Zhang S, Ruegg PL, Saddique U, Han B: Characteristics and genetic diversity of multi-drug resistant extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolated from bovine mastitis. Oncotarget 2017, 8 (52): 90144-90163.10.18632/oncotarget.21496568573829163817
]Search in Google Scholar
[
38. Singh F, Sonawane GG, Kumar J, Dixit SK, Meena RK, Tripathi BN: Antimicrobial resistance and phenotypic and molecular detection of extended-spectrum ß-lactamases among extraintestinal Escherichia coli isolated from pneumonic and septicemic sheep and goats in Rajasthan, India. Turk J Vet Anim Sci 2019, 43: 754-760.10.3906/vet-1905-1
]Search in Google Scholar
[
39. Chia JH, Siu LK, Su LH, Lin HS, Kuo AJ, Lee MH, Wu TL: Emergence of carbapenem-resistant Escherichia coli in Taiwan: Resistance due to combined CMY-2 production and porin deficiency. J Chemother 2009, 21(6): 621-626.10.1179/joc.2009.21.6.62120071284
]Search in Google Scholar
[
40. Lister PD, Wolter DJ, Hanson ND: Antibacterial-resistant Pseudomonas aeruginosa: Clinical impact and complex regulation of chromosomally encoded resistance mechanismis. Clin Microbiol Rev 2009, 22: 582-610.10.1128/CMR.00040-09277236219822890
]Search in Google Scholar
[
41. Naas T, Oueslati S, Bonnin RA, Dabos ML, Zavala A, Dortet L, Retailleau P, Iorga BI: Β-lactamase database (BLDB)-structure and function. J Enzyme Inhib Med Chem 2017, 32 (1): 917-919.10.1080/14756366.2017.1344235644532828719998
]Search in Google Scholar
[
42. Palmeira JD, Ferreira HMN: Extended-spectrum β-lactamase (ESBL)- producing Enterobactericeae in cattle production- a threat around the world. Heliyon 2020, 6 (1): e03206.10.1016/j.heliyon.2020.e03206700283832042963
]Search in Google Scholar
[
43. Schwaber MJ, Carmeli Y: Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007, 60 (5): 913-920.10.1093/jac/dkm31817848376
]Search in Google Scholar